GORZEGNO G[au] - Search Results

Year	Number of Results
1981	1
1987	1
1992	3
1993	1
1994	1
1995	1
1996	2
1997	3
1999	2
2000	4
2001	6
2002	4
2003	2
2004	1
2005	4
2006	4
2007	1
2008	2
2009	3
2010	1
2011	1
2019	2
2020	2
2024	0

1

Potential clinical value of circulating chromogranin A in patients with prostate carcinoma.

Berruti A, Dogliotti L, Mosca A, Gorzegno G, Bollito E, Mari M, Tarabuzzi R, Poggio M, Torta M, Fontana D, Angeli A. Berruti A, et al. Among authors: gorzegno g. Ann Oncol. 2001;12 Suppl 2:S153-7. doi: 10.1093/annonc/12.suppl_2.s153. Ann Oncol. 2001. PMID: 11762344 Free article. Review.

2

Systemic recurrence of endometrial cancer more than 10 years after hysterectomy: a report of two cases and a brief review of the literature.

Muratori L, Sperone P, Gorzegno G, La Salvia A, Scagliotti GV. Muratori L, et al. Among authors: gorzegno g. J Egypt Natl Canc Inst. 2020 Nov 2;32(1):41. doi: 10.1186/s43046-020-00052-2. J Egypt Natl Canc Inst. 2020. PMID: 33135114 Free article. Review.

3

Background to and management of treatment-related bone loss in prostate cancer.

Berruti A, Tucci M, Terrone C, Gorzegno G, Scarpa RM, Angeli A, Dogliotti L. Berruti A, et al. Among authors: gorzegno g. Drugs Aging. 2002;19(12):899-910. doi: 10.2165/00002512-200219120-00002. Drugs Aging. 2002. PMID: 12495366 Review.

4

The clinical management of neuroendocrine tumors with long-acting repeatable (LAR) octreotide: comparison with standard subcutaneous octreotide therapy.

Dogliotti L, Tampellini M, Stivanello M, Gorzegno G, Fabiani L. Dogliotti L, et al. Among authors: gorzegno g. Ann Oncol. 2001;12 Suppl 2:S105-9. doi: 10.1093/annonc/12.suppl_2.s105. Ann Oncol. 2001. PMID: 11762334 Free article. Review.

5

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment.

Muratori L, Gorzegno G, Sperone P, Andreozzi A, Di Maio M, Scagliotti GV. Muratori L, et al. Among authors: gorzegno g. Gynecol Oncol Rep. 2019 Feb 16;28:44-46. doi: 10.1016/j.gore.2019.02.004. eCollection 2019 May. Gynecol Oncol Rep. 2019. PMID: 30859116 Free PMC article.

6

Multimodal management of stages III-IVa malignant thymoma.

Bretti S, Berruti A, Loddo C, Sperone P, Casadio C, Tessa M, Ardissone F, Gorzegno G, Sacco M, Manzin E, Borasio P, Sannazzari GL, Maggi G, Dogliotti L; Piemonte Oncology Network. Bretti S, et al. Among authors: gorzegno g. Lung Cancer. 2004 Apr;44(1):69-77. doi: 10.1016/j.lungcan.2003.09.022. Lung Cancer. 2004. PMID: 15013585

7

Long-term disease control in a metastatic squamous cell carcinoma of the oral cavity treated with maintenance metronomic capecitabine.

Muratori L, La Salvia A, Gorzegno G, Sperone P, Scagliotti GV. Muratori L, et al. Among authors: gorzegno g. J Oncol Pharm Pract. 2020 Jan;26(1):240-243. doi: 10.1177/1078155219845433. Epub 2019 May 1. J Oncol Pharm Pract. 2020. PMID: 31042137

8

Development and validation of a patient-physician relationship index in the advanced cancer setting.

Ostacoli L, Costantini M, Beccaro M, Dellai M, Gorzegno G, Picci RL, Sguazzotti E, Berruti A, Torta R, Furlan PM. Ostacoli L, et al. Among authors: gorzegno g. Tumori. 2007 Sep-Oct;93(5):485-90. doi: 10.1177/030089160709300513. Tumori. 2007. PMID: 18038882

9

Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients.

Berruti A, Mosca A, Bitossi R, Gorzegno G, Guercio S, Poggio M, Tampellini M, Porpiglia F, Ostellino O, Scarpa RM, Dogliotti L. Berruti A, et al. Among authors: gorzegno g. Anticancer Res. 2005 Nov-Dec;25(6C):4475-9. Anticancer Res. 2005. PMID: 16334129 Free article. Clinical Trial.

10

Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design.

Berruti A, Bitossi R, Gorzegno G, Bottini A, Alquati P, De Matteis A, Nuzzo F, Giardina G, Danese S, De Lena M, Lorusso V, Farris A, Sarobba MG, DeFabiani E, Bonazzi G, Castiglione F, Bumma C, Moro G, Bruzzi P, Dogliotti L; Epirubicin-Lonidamine Group, Orbassano, Torino, Italy. Berruti A, et al. Among authors: gorzegno g. J Clin Oncol. 2002 Oct 15;20(20):4150-9. doi: 10.1200/JCO.2002.08.012. J Clin Oncol. 2002. PMID: 12377958 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year